MSX1—A Potential Marker for Uterus-Preserving Therapy of Endometrial Carcinomas

MSX1—A Potential Marker for Uterus-Preserving Therapy of Endometrial Carcinomas

Prognostic factors are of great interest in patients with endometrial cancer. One potential factor could be the protein MSX1, a transcription repressor, that has an inhibitory effect on the cell cycle. For this study, endometrioid endometrial carcinomas (<i>n </i>= 53), clear cell endome...

Full description

Bibliographic Details
Main Authors: Simon Eppich, Christina Kuhn, Elisa Schmoeckel, Doris Mayr, Sven Mahner, Udo Jeschke, Julia Gallwas, Helene Hildegard Heidegger
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:International Journal of Molecular Sciences
Subjects:
MSX1
endometrial carcinoma
cell-cycle
DNA-methylation
uterus-preserving therapy
Online Access:https://www.mdpi.com/1422-0067/21/12/4529

Internet

https://www.mdpi.com/1422-0067/21/12/4529

Similar Items